Market Place
Sourcing Support
Valo Health Completes Enrollment of OPL-0401 Phase 2 Study
04 Mar 2024 //
PR NEWSWIRE
Valo Health Announces Changes to its Board of Directors and Leadership Team
16 Jan 2024 //
PR NEWSWIRE
Valo Health - FDA Collaborative Study in Cardiac Tissues Shows Potential
14 Dec 2022 //
PRNEWSWIRE
Valo Health To Participate in Piper Sandler`s 34th Annual Healthcare Conference
16 Nov 2022 //
PRNEWSWIRE
Valo Health Begins Dosing in OPL-0401 PII study of an oral ROCK1/2 inhibitor
18 Aug 2022 //
PRNEWSWIRE
Charles River and Valo Launch Logica to Rapidly Deliver Optimized PC Assets
27 Apr 2022 //
BUSINESSWIRE
Charles River, Valo Health Partner to Provide Access to AI-Enabled DDS
19 Jan 2022 //
BUSINESSWIRE
Valo blames `market conditions` for end of $750M Khosla deal
18 Nov 2021 //
BIOSPACE
Flagship and Khosla Ventures team up for biotech`s latest SPAC
09 Jun 2021 //
ENDPTS
Valo and ImmunoScape identify peptides for coronavirus vaccine development
10 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
Valo Health grabs $110M top-up, bringing series B to $300M
09 Mar 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.